|
2023
|
Invention
|
Uridine triacetate amorphous formulation and uses thereof. There is disclosed a dispersion of amo... |
|
2022
|
Invention
|
Compositions and compounds for co-delivery of uridine and ketoleucine. Compounds and compositions... |
|
|
Invention
|
Uridine triacetate amorphous formulation. There is disclosed a dispersion of amorphous uridine tr... |
|
2021
|
Invention
|
Imidazoquinoline compound having anti-inflammatory, antifungal, antiparasitic, and anticancer act... |
|
|
Invention
|
5'-o-phenylacetyluridine and therapeutic use. 5' -O-Phenylacetyluridine effectively delivers both... |
|
|
Invention
|
2',3'-diacetyluridine substituted with acetoacetyl at the 5' position. 5'-O-(Acetoacetyl)-2',3'-d... |
|
2020
|
Invention
|
Formulations of uridine triacetate in triacetin. This invention provides a solution comprising ur... |
|
2019
|
Invention
|
Compositions and devices for systemic delivery of uridine. A solution of uridine in saline, and o... |
|
2018
|
G/S
|
Pharmaceutical preparations for treatment in the areas of oncology, hematology, neurology, dermat... |
|
2017
|
G/S
|
Pharmaceutical preparations for treatment in the areas of hematology, dermatology, metabolic diso... |
|
2015
|
G/S
|
Pharmaceutical products, namely, uridine triacetate, other uridine prodrugs and preparations for ... |
|
|
G/S
|
Pharmaceutical products and preparations; Pharmaceutical products and preparations for use in the... |
|
|
Invention
|
Treatment of glycosylation deficiency diseases. Uridine triacetate or other uridine prodrugs are ... |
|
|
G/S
|
Pharmaceutical products and preparations for use in the fields of oncology, mitochondrial disease... |
|
2014
|
G/S
|
Pharmaceutical preparations for treatment in the areas of oncology, hematology, neurology, namely... |
|
|
Invention
|
Amine compounds having anti-inflammatory, antifungal, antiparasitic and anticancer activity. Amin... |
|
2013
|
Invention
|
Stem cell mobilization and tissue repair and regeneration. Stem cells are mobilized from bone mar... |
|
|
Invention
|
Compounds for the treatment of metabolic disorders. Compounds useful for the treatment of various... |
|
|
Invention
|
Combination treatment for metabolic disorders.
Various metabolic disorders, such as insulin resi... |
|
2012
|
Invention
|
Stem cell mobilization and tissue repair and regeneration.
Stem cells are mobilized from bone ma... |
|
|
Invention
|
3-benzyloxyphenyloxoacetic acid compounds for reducing uric acid. Uric acid in mammalian subjects... |
|
2011
|
Invention
|
Benzoic acid compounds for reducing uric acid.
Uric acid in mammalian subjects is reduced and ex... |
|
|
Invention
|
Benzoic acid compounds for reducing uric acid. Uric acid in mammalian subjects is reduced and exc... |
|
|
Invention
|
Compounds for the treatment of metabolic disorders.
Agents useful for the treatment of various m... |
|
|
Invention
|
Compositions and methods for treatment of mitochondrial diseases. Compounds, compositions, and me... |
|
2010
|
Invention
|
3-substituted compounds for reducing uric acid. Uric acid in mammalian subjects is reduced and ex... |
|
|
Invention
|
Determining the severity of 5-fluorouracil overdose.
A severity score for 5-fluorouracil (5FU) t... |
|
|
Invention
|
Determining the severity of 5-fluorouracil overdose. A severity score for 5-fluorouracil (5FU) to... |
|
2009
|
Invention
|
Synthesis of (phenylalkyloxy)phenyl-oxobutanoic acids. A method for synthesizing (phenylalkyloxy)... |
|
|
Invention
|
Hemoglobin alpha chain peptide fragments useful for inhibiting stem cell proliferation.
Disclose... |
|
|
Invention
|
Synthesis of 4-[3-(2,6-dimethylbenzyloxy)phenyl]-4-oxobutanoic acid. The compound 4-[3-(2,6-Dimet... |
|
|
Invention
|
Tetrazole compounds for reducing uric acid. Uric acid in mammalian subjects is reduced and excret... |
|
|
Invention
|
Compounds and method for reducing uric acid. Uric acid in mammalian subjects is reduced and excre... |
|
|
Invention
|
Compounds for the treatment of metabolic disorders. Agents useful for the treatment of various me... |
|
2008
|
Invention
|
Compositions for the treatment of metabolic disorders. Agents useful for the treatment of various... |
|
2007
|
Invention
|
Compounds for the treatment of metabolic disorders.
Compounds useful for the treatment of variou... |
|
|
Invention
|
Combination treatment for metabolic disorders. Various metabolic disorders, such as insulin resis... |
|
|
Invention
|
Method for the treatment of metabolic disorders. Compounds useful for the treatment of various me... |
|
|
Invention
|
Compounds for the treatment of metabolic disorders. 3-(2,4-Bis(trifluoromethyl)benzyloxy)phenylac... |
|
|
Invention
|
Combination treatment of metabolic disorders. Various metabolic disorders, such as insulin resist... |
|
|
Invention
|
Compounds for the treatment of metabolic disorders. 5 is hydrogen or alkyl having one, two, three... |
|
2002
|
G/S
|
Pharmaceutical preparations for treatment in the areas of oncology, hematology, namely, disorders... |
|
|
G/S
|
Pharmaceuticals and biological products; pharmaceuticals and biologicals in the fields of oncolog... |
|
|
G/S
|
Pharmaceuticals and biologicals in the fields of oncology, hematology, and others. Pharmaceutical... |
|
|
G/S
|
Pharmaceutical preparations for treatment in the areas of oncology, [ hematology, ] neurology, [ ... |
|
|
G/S
|
PHARMACEUTICAL PREPARATIONS FOR TREATMENT IN THE AREAS OF ONCOLOGY, HEMATOLOGY, NEUROLOGY, DERMAT... |
|
1995
|
Invention
|
Oxpurine nucleosides and their congeners, and acyl, derivatives thereof, for improvement of hemat... |
